Endoscopic Ultrasound–Guided Chemoablation of an Acinar Cell Carcinoma as a Suppressive Strategy for Unresectable Disease
Acinar cell carcinoma is a relatively rare pancreatic neoplasm, typically treated with surgical resection and adjuvant chemotherapy; however, definitive treatment protocols are not well established. We describe endoscopic ultrasound-guided chemoablation with fine needle injection of paclitaxel/gemcitabine in conjunction with chemotherapy in a 78-year-old man with a 3.0 × 2.7-cm acinar cell carcinoma who was not a surgical candidate. At 12 months, the mass had reduced in size to 0.9 × 0.9 cm, followed by steady growth to 6 × 4.5 cm at 24 months when the patient died secondary to unrelated causes.
Authors
- Brandon Rodgers
- Matthew T. Moyer (ORCID: https://orcid.org/0000-0002-6873-7493)
Institutions
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- ACG Case Reports Journal
- Published
- 2025-04-01
- DOI
- https://doi.org/10.14309/crj.0000000000001664
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00